Farxiga Related Clinical Trials
Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes [Recruiting]
Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy Participants [Completed]
Bioequivalence/Food Effect - Saxa/Dapa Dual Fixed Dose Combination (FDC) [Completed]
Effects of Dapagliflozin 10 mg on Insulin Resistance in Patients With Type 2 Diabetes Mellitus. [Recruiting]
Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of Ultra Low Doses of Dapagliflozin in Healthy Subjects [Completed]
A Phase IIA Study of BMS-512148 to Assess Safety, Exposure, and Biological Effects in Stable Type 2 Diabetic Subjects [Completed]
Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes [Completed]
Does Dapagliflozin Augment The Favorable Adaptation To Endurance Exercise Training? [Recruiting]
PK Study of Dapagliflozin in Pediatric Subjects With T2DM [Completed]
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes [Completed]
Mechanistic Study of the Systolic Blood Pressure Lowering Effect of Dapagliflozin in Type 2 Diabetes [Recruiting]
A Study to Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 Diabetes [Recruiting]
Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin [Recruiting]
Does Dapagliflozin Promote Favorable Health Benefits That Are Independent Of Weight Loss? [Recruiting]
Study to Assess the Effect of Food on Combination Dapagliflozin/Metformin Tablet in Healthy Volunteers [Completed]
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone [Completed]
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes [Completed]
A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets [Completed]
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise [Completed]
Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects [Completed]
Dapagliflozin in Type 1 Diabetes [Recruiting]
Effect of Dapagliflozin Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion [Completed]
Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptinin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea [Not yet recruiting]
Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes [Completed]
A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone [Completed]
A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise [Completed]
A Study to Compare the Pharmacodynamics of Canagliflozin and Dapagliflozin in Healthy Volunteers [Completed]
Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment [Completed]
Phase 3 28 Week Study and 24 Week Extension to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo [Recruiting]
Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy Subjects [Completed]
Characterization of the Kinetics of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus (T2DM) [Completed]
A Study to to Assess the Effect of Dapagliflozin When Administered Once a Day Versus Twice a Day on Blood Glucose [Completed]
Effect of Dapagliflozin on Glycemic Variability [Not yet recruiting]
An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets [Completed]
Drug-drug Interaction Study of Dapagliflozin With Voglibose in Japanese Type 2 Diabetes Mellitus Patients [Completed]
To Compare the Similarity of a Combination Dapagliflozin/Metformin Tablet With the Two Drugs Administered Separately [Completed]
Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight [Active, not recruiting]
Vildagliptin Versus Dapagliflozin on Glucagon [Not yet recruiting]
Effect of Dapagliflozin on Microvascular and Macrovascular Circulation and Total Body Sodium Content [Recruiting]
Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects [Completed]
Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects [Completed]
Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes [Completed]
Phase III Insulin Add-On Asia Regional Program - ST [Recruiting]
Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus Patients [Completed]
Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects [Completed]
Effects of Dapagliflozin on the Incretin Sensitivity of the Pancreatic Beta Cell [Recruiting]
Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes [Completed]
Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 Diabetes [Completed]
Dapagliflozin DPPIV Inhibitor add-on Study [Completed]
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes [Recruiting]
Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients [Completed]
Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin [Completed]
The Effects of Dapagliflozin on HDL Particles Subtypes and Reverse Cholesterol Transport in Type 2 Diabetic Patients [Not yet recruiting]
Evaluation of Dapagliflozin Taken Twice-daily [Completed]
Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea [Completed]
An Investigation Into The Anti-hypertensive And Potential Anti-inflammatory Actions Of Dapagliflozin [Not yet recruiting]
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone [Recruiting]
Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients [Completed]
A Study to Investigate Effects of Omega-3 Carboxylic Acids and Dapagliflozin on Liver Fat Content in Diabetic Patients [Recruiting]
Drug Interaction With Metformin [Completed]
Bioequivalence Study Coadministered to Healthy Subjects in the Fasted State [Completed]
A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Without Control on Metformin Alone [Recruiting]
A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes [Completed]
Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes [Completed]
A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus [Completed]
Add-on to Thiazolidinedione (TZD) Failures [Completed]
Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State [Completed]
Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus [Completed]
Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy [Not yet recruiting]
Effects of Dapagliflozin on Epicardial Fat in Subjects With Type 2 Diabetes [Not yet recruiting]
Renal Mechanism of Action/Splay vs. TmG [Terminated]
Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects [Completed]
Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy Subjects [Terminated]
Glucose Control During Glucocorticoid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease [Recruiting]
Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension [Completed]
Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease [Completed]
Evaluation of Efficacy and Safety of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Diet and Exercise Alone [Suspended]
Study of Dapagliflozin on Mitochondrial Dysfunction and Impaired Insulin Signaling/Action [Recruiting]
Saxagliptin in Combination With Dapagliflozin - Effects on Islet Cell Function [Not yet recruiting]
Effect of Dapagliflozine on Systemic and Renal Endothelial Function [Recruiting]
Safety and Effectiveness of SGLT-2 Inhibitors in Patients With Heart Failure and Diabetes [Recruiting]
Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes [Completed]
Renal Impairment in Type 2 Diabetic Subjects [Completed]
Phase I Multiple-Ascending Dose (Japan) [Completed]
Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes Mellitus [Completed]
Phase 1 Study to Explore the Safety and Pharmacokinetics of DAPAglifozin in Adolescents and Adults With Type 1 Diabetes [Recruiting]
Forxiga Prescription Event Monitoring Program [Recruiting]
Forxiga (Dapagliflozin) Regulatory Postmarketing Surveillance [Recruiting]
Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors [Recruiting]
|
